![Eldar Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Eldar Kim is the founder of MSM Protein Technologies, Inc. He held the title of Director & Chief Scientific Officer since the company's founding in 2005.
Aktive Positionen von Eldar Kim
Unternehmen | Position | Beginn |
---|---|---|
MSM Protein Technologies, Inc.
![]() MSM Protein Technologies, Inc. Pharmaceuticals: MajorHealth Technology MSM Protein Technologies is an early drug development company that specializes in antibody drug discovery against integral membrane proteins. MSM Protein Technologies is based in Waltham, MA and was founded in 2005 by Davis Farmer, Eldar Kim, and David Kreimer. The private company has a solid record of successful partnerships with big pharma companies in drug discovery and development programs. The company's pipeline includes a number of first-in-class pre-clinical stage antibodies targeting several GPCRs, mainly focused on immunologic and oncologic diseases such as blood cancers, solid tumors, autoimmune diseases, and respiratory diseases. | Gründer | 01.01.2005 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
MSM Protein Technologies, Inc.
![]() MSM Protein Technologies, Inc. Pharmaceuticals: MajorHealth Technology MSM Protein Technologies is an early drug development company that specializes in antibody drug discovery against integral membrane proteins. MSM Protein Technologies is based in Waltham, MA and was founded in 2005 by Davis Farmer, Eldar Kim, and David Kreimer. The private company has a solid record of successful partnerships with big pharma companies in drug discovery and development programs. The company's pipeline includes a number of first-in-class pre-clinical stage antibodies targeting several GPCRs, mainly focused on immunologic and oncologic diseases such as blood cancers, solid tumors, autoimmune diseases, and respiratory diseases. | Health Technology |